Every September, we join with friends across the cancer community in recognizing and honoring our most vulnerable cancer patients: kids. Childhood Cancer Awareness Month (CCAM) is a yearly reminder of the sacrifices and struggles that children and their families face after a cancer diagnosis, as well as the triumphs, achievements, and spirit of these brave […]
Liquid Biopsies for Brain Tumors: Can We Improve Diagnosis, Treatment Decisions, and Research All Via One Advancement?
New research, supported by the Defeat GBM Research Collaborative, is paving the way for new advances in the diagnosis, monitoring, treatment planning, and research of brain tumors – both primary and metastatic. Dr. Ingo Mellinghoff – one of the Principle Investigators in the Defeat GBM Research Collaborative – and his colleagues at Memorial Sloan Kettering […]
Earlier this week, the National Brain Tumor Society announced the addition of three new members to our national Board of Directors. Each new member brings an exciting and diverse range of knowledge and expertise and all three bring the same dedication, and personal connection to our cause that the rest of our terrific Board has. It is without further […]